Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network - Wikidata - awgldk - TriplyDB

Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network

Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network

http://www.wikidata.org/entity/Q36726996

about

A Review of Systemic Treatment in Metastatic Triple-Negative Breast Cancer Molecular and Genetic Predictors of Breast-to-Brain Metastasis: Review and Case Presentation Targeting the androgen receptor in prostate and breast cancer: several new agents in development Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State.Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study Opportunities for improving triple‐negative breast cancer outcomes: results of a population‐based study US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer Efficacy of carboplatin-based preoperative chemotherapy for triple-negative breast cancer. A meta-analysis of randomized controlled trials Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study.Computational analysis of mRNA expression profiles identifies the ITG family and PIK3R3 as crucial genes for regulating triple negative breast cancer cell migration The prognosis analysis of different metastasis pattern in patients with different breast cancer subtypes: a SEER based study A BRCA1 deficient-like signature is enriched in breast cancer brain metastases and predicts DNA damage-induced poly (ADP-ribose) polymerase inhibitor sensitivity.Correlation Factors Analysis of Breast Cancer Tumor Volume Doubling Time Measured by 3D-Ultrasound Molecular breast cancer subtypes and therapies in a public hospital of northeastern Brazil.PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors.HER-2 positive breast cancer is associated with an increased risk of positive cavity margins after initial lumpectomy.YC-1 inhibits proliferation of breast cancer cells by down-regulating EZH2 expression via activation of c-Cbl and ERK Leptomeningeal metastases in breast cancer.Androgen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic options.Expanded Indications and Improved Outcomes for Nipple-Sparing Mastectomy Over Time.Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors Selective inhibition of EZH2 by ZLD1039 blocks H3K27 methylation and leads to potent anti-tumor activity in breast cancer.Racial differences in outcomes of triple-negative breast cancer Lipid analysis of eight human breast cancer cell lines with ToF-SIMS.Prognostic effect analysis of molecular subtype on young breast cancer patients Health disparities across the breast cancer continuum Triple negative breast cancer in North of Morocco: clinicopathologic and prognostic features A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer.Breast carcinoma subtypes show different patterns of metastatic behavior.Quantitative Gene Expression by Recurrence Score in ER-Positive Breast Cancer, by Age.Decreased Wnt5a Expression is a Poor Prognostic Factor in Triple-Negative Breast Cancer.Prognostic role of PIK3CA mutations of cell-free DNA in early-stage triple negative breast cancer.Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients.Estrogen promotes the brain metastatic colonization of triple negative breast cancer cells via an astrocyte-mediated paracrine mechanism Breast cancer brain metastases: new directions in systemic therapy Prognostic value of FDG PET/CT-based metabolic tumor volumes in metastatic triple negative breast cancer patients Features of triple-negative breast cancer: Analysis of 38,813 cases from the national cancer database Deriving clinically meaningful cut-scores for fatigue in a cohort of breast cancer survivors: a Health, Eating, Activity, and Lifestyle (HEAL) Study.The potential role of nanotechnology in therapeutic approaches for triple negative breast cancer.

P2860

Q26752846-8D812A35-0555-400C-8D01-CAD7A7B7D3FC Q26800626-FF53616E-4905-4610-875C-3DE94F7C03A9 Q27009424-610BE0DF-405C-476D-B1A5-5F6F3A47DE4F Q27300459-6FD53700-1DE3-424E-A1BB-8A5288895149 Q29248323-F897FBC4-5050-418F-9FC5-62351795B62E Q29248325-548E9A79-AC0C-4A8B-850A-BE8F29B1C8D9 Q30665329-A6201C7D-DEDF-4CDE-A96D-2106FB18C89F Q33414349-83CEBB29-8E1F-448A-9351-FAB735DB75A9 Q33438050-59E83052-E6D8-4A64-B6FB-4161C05DDE8E Q33619700-EB655F94-B1C5-4CEB-B138-24572A3B1F14 Q33657062-45A323CF-264D-4E38-872D-C9500C373AEE Q33688668-375E594E-E1E7-4E17-A9C2-CF4C75334516 Q33739161-3ACC386F-7ACB-48E6-AAC0-78EB32B6726D Q33874429-0EBC71C9-D368-46E6-AE9F-3071769223A3 Q34196915-EE18BD2D-4A78-40FE-9F17-A6A59EFF2F2A Q34296476-276064A3-8E99-436B-82FE-D027210FBAFA Q34309459-ED70E1E6-2EFC-467F-AF62-5D50D8D1C3D3 Q34571374-9F260067-5543-4AC4-8AE6-25C3547FF08D Q34650605-49FB25E1-DF20-4609-B4B8-EB403D17821A Q35088745-AA7DB075-8A2B-4A02-8737-D7E2D723B2C6 Q35707085-66176BA2-27D6-4A5C-8E24-E1F3D4D2F990 Q35801283-23086F98-C601-48CB-98DE-41AC88EC688F Q35921549-42C3F81F-38B5-4398-B0B7-D9CF066DFA1B Q35956986-6663197B-093F-4C6F-AD32-663F9D555844 Q36004758-7A820EEA-ED40-4C47-908D-2D1228863C4F Q36029962-83DA2536-3EA1-4EDD-AF9D-36C2B6844932 Q36136670-B60EB174-9569-43DF-915E-5CD704EC0D54 Q36172054-EB252ABB-BDE8-4AE0-9703-6A8B63B7E92C Q36244860-1C500969-5F64-4993-B1BC-46E58A99320E Q36253544-023EF2B7-74EE-4092-9C33-B733070325DC Q36373733-6CB0154E-4030-43CC-9653-D77FCA19B5AA Q36429159-1DE59214-4435-4BF9-A7F8-5D56C69CFB5D Q36467458-00D442FF-3FF4-4FB3-8F16-FDF19D04D644 Q36651026-92C77E68-A2B4-475B-A598-1B1123021631 Q36734590-8A477558-B143-46AF-A28F-B24C18D9AF09 Q36822500-2E1BD83B-A69E-4B2A-9C2C-1B51793AC8FA Q36874902-C82595F5-F467-4032-9103-591CECF0C0D4 Q37226242-5B391C14-9B62-4F33-AA5A-5D17F68AA4FB Q37296936-E3D16A00-B062-4943-8382-50A0DE32E543 Q37304764-B965849E-92D2-4752-BF66-70A1C5C54DC9

P2860

Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network

http://www.wikidata.org/entity/Q36726996

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Clinicopathologic features, pa ...... l Comprehensive Cancer Network

@ast

Clinicopathologic features, pa ...... l Comprehensive Cancer Network

@en

type

label

Clinicopathologic features, pa ...... l Comprehensive Cancer Network

@ast

Clinicopathologic features, pa ...... l Comprehensive Cancer Network

@en

prefLabel

Clinicopathologic features, pa ...... l Comprehensive Cancer Network

@ast

Clinicopathologic features, pa ...... l Comprehensive Cancer Network

@en

P1433

Q36726996-54C0DA1F-FA32-4A49-887F-039A7995244D

P1476

Q36726996-B0C0C0F0-2AA9-4ABF-9DDC-658DC85AE21A

P2093

Q36726996-07F70B33-3B00-4079-B47C-FFA8EEA2DC40

Q36726996-17F84B7C-3925-42FB-9D7B-6F53FC26E259

Q36726996-3A757515-DCA7-4E5A-A3BC-4AF5063D6163

Q36726996-989C3E7D-BECE-4F59-93A0-90FCC04C5333

Q36726996-A8DBB710-E304-42B9-A67E-472D201C6AB6

Q36726996-CFB3B3B6-9DAA-47E5-A07A-F10C38B8DC59

Q36726996-D5B72A37-B220-4209-A014-B9CFB1286EA6

Q36726996-D8F479E8-7690-47C3-9318-74512FAAACE8

Q36726996-E54D8199-9CED-48C4-821E-810798A1A2D6

Q36726996-FA56489B-7820-488D-A62C-5C96D37AAF62

P2860

Q36726996-018F8978-C869-4CE9-BAB3-22DCA67EE182

Q36726996-024E416D-6956-43DD-B6DF-727793F29DF5

Q36726996-087F462E-86A7-4EB6-AACE-AAB6B577D025

Q36726996-0A0EB47F-2F66-4274-9389-B0952EB80666

Q36726996-0AC3A0A7-B8C7-4074-A689-4D56693FEC40

Q36726996-0D32D002-4715-48A6-8300-67B87C854093

Q36726996-1A182FE7-3F97-416B-A213-D43631312242

Q36726996-221D18BB-97C9-4D95-8F86-76D018967448

Q36726996-2FFAEAFD-2E2C-480B-8E0E-DF6944D9E881

Q36726996-33BE1741-D871-43E1-904B-EACCEF6E0782

P304

Q36726996-9E49A60B-305C-43EB-AFDE-52248C868823

P31

Q36726996-A1FE3810-528B-4EFA-B3FC-1DE57ADE7318

P356

Q36726996-638C88C8-7CC6-4205-BEC1-2D8E2A433AF0

P407

Q36726996-C97AAAFC-0AAD-4C48-96A2-F567C9011DBE

P433

Q36726996-DFB9D30E-657B-492F-810B-57F30DED1336

P478

Q36726996-3A4960E2-B7AC-4133-B68A-5EBBBEE12717

P577

Q36726996-AB5369A0-B762-499E-B342-B6045EFB7E50

P5875

Q36726996-66AE3DD8-AF7A-4712-9DF1-E6139C06D47E

P698

Q36726996-2C56283C-6DB1-43BE-B534-1D4630F0A478

P932

Q36726996-5AB4FD0D-315F-42AB-84F1-7A9896678A65

P356

P1433

P1476

Clinicopathologic features, pa ...... l Comprehensive Cancer Network

@en

P2093

Ann Vanderplas

http://www.w3.org/2001/XMLSchema#string

Douglas W Blayney

http://www.w3.org/2001/XMLSchema#string

Eric P Winer

http://www.w3.org/2001/XMLSchema#string

Jane C Weeks

http://www.w3.org/2001/XMLSchema#string

Joyce C Niland

http://www.w3.org/2001/XMLSchema#string

Melissa E Hughes

http://www.w3.org/2001/XMLSchema#string

Nancy U Lin

http://www.w3.org/2001/XMLSchema#string

Richard L Theriault

http://www.w3.org/2001/XMLSchema#string

Stephen B Edge

http://www.w3.org/2001/XMLSchema#string

Yu-Ning Wong

http://www.w3.org/2001/XMLSchema#string

P2860

The epidemiology of triple-negative breast cancer, including race

Molecular portraits of human breast tumours

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue repository of the Surveillance, Epidemiology, and End Results (SEER) program.

Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases.

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer.

Epidemiology of basal-like breast cancer.

Triple-negative breast cancer: clinical features and patterns of recurrence.

Adjuvant chemotherapy in older women with early-stage breast cancer.

Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342

P304

5463-5472

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.27581

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224868272

http://www.w3.org/2001/XMLSchema#string

P698

22544643

http://www.w3.org/2001/XMLSchema#string

P932

3611659

http://www.w3.org/2001/XMLSchema#string